These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26092643)

  • 21. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts.
    Wu JF; Chang MH
    J Biomed Sci; 2015 Oct; 22():92. PubMed ID: 26487087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.
    Vaillant A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33922828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
    Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F
    PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
    Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
    BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B.
    Liu Y; Li H; Yan X; Wei J
    J Viral Hepat; 2019 Jul; 26 Suppl 1():69-76. PubMed ID: 31380585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.
    Ma Z; Zhang E; Gao S; Xiong Y; Lu M
    Front Immunol; 2019; 10():2308. PubMed ID: 31608073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    European Association for the Study of the Liver
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel targets for hepatitis B virus therapy.
    Testoni B; Durantel D; Zoulim F
    Liver Int; 2017 Jan; 37 Suppl 1():33-39. PubMed ID: 28052622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus: new therapeutic perspectives.
    Lin CL; Yang HC; Kao JH
    Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting hepatitis B virus cccDNA using CRISPR/Cas9.
    Kennedy EM; Kornepati AV; Cullen BR
    Antiviral Res; 2015 Nov; 123():188-92. PubMed ID: 26476375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
    Werle-Lapostolle B; Bowden S; Locarnini S; Wursthorn K; Petersen J; Lau G; Trepo C; Marcellin P; Goodman Z; Delaney WE; Xiong S; Brosgart CL; Chen SS; Gibbs CS; Zoulim F
    Gastroenterology; 2004 Jun; 126(7):1750-8. PubMed ID: 15188170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of viral hepatitis B.
    Pramoolsinsup C
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral hepatitis B: established and emerging therapies.
    Balsano C; Alisi A
    Curr Med Chem; 2008; 15(9):930-9. PubMed ID: 18473801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history and prognosis of hepatitis B.
    Fattovich G
    Semin Liver Dis; 2003 Feb; 23(1):47-58. PubMed ID: 12616450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Trial Design for Immune-Based Therapy of Hepatitis B Virus.
    Gill US; Bertoletti A
    Semin Liver Dis; 2017 May; 37(2):85-94. PubMed ID: 28564718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
    Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBV cure: why, how, when?
    Levrero M; Testoni B; Zoulim F
    Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.